Chemomab Therapeutics Ltd. Operating Expenses
Chemomab Therapeutics Ltd. (CMMB) reported Operating Expenses of $9.57 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-03-23
- Chemomab Therapeutics Ltd. operating expenses for the quarter ending 2024-06-30 was $3.77M, a 54.02% decline year-over-year.
- Chemomab Therapeutics Ltd. operating expenses for the quarter ending 2023-06-30 was $8.20M, a 31.04% increase year-over-year.
- Chemomab Therapeutics Ltd. operating expenses for the quarter ending 2023-03-31 was $9.05M, a 70.09% increase year-over-year.
- Chemomab Therapeutics Ltd. operating expenses for the quarter ending 2022-12-31 was $8.64M, a 72.01% increase year-over-year.
- Chemomab Therapeutics Ltd. operating expenses for fiscal 2020 was $5.97M, a 73.92% decline from fiscal 2019.
- Chemomab Therapeutics Ltd. operating expenses for fiscal 2019 was $22.90M, a 75.67% increase from fiscal 2018.
- Chemomab Therapeutics Ltd. operating expenses for fiscal 2018 was $13.04M.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $9.57M 20-F · filed 2026-03-23 | |||||||
| 2025-06-30 | $5.75M 6-K · filed 2025-08-14 | |||||||
| 2024-12-31 | $14.74M 20-F · filed 2026-03-23 | |||||||
| 2024-06-30 | $3.77M 6-K · filed 2024-08-21 | $7.82M 6-K · filed 2025-08-14 | ||||||
| 2023-12-31 | $25.46M 20-F · filed 2026-03-23 | |||||||
| 2023-06-30 | $8.20M 6-K · filed 2024-08-21 | $17.24M 6-K · filed 2024-08-21 | $25.89M derived: sum of 3 quarters · filed 2025-04-04 | $34.20M derived: sum of 4 quarters · filed 2025-04-04 | ||||
| 2023-03-31 | $9.05M 10-Q · filed 2023-05-11 | $17.69M derived: sum of 2 quarters · filed 2025-04-04 | $26.01M derived: sum of 3 quarters · filed 2025-04-04 | $32.26M derived: sum of 4 quarters · filed 2025-04-04 | ||||
| 2022-12-31 | $8.64M derived: 20-F 12 month − 10-Q 9 month · filed 2025-04-04 | $16.96M derived: sum of 2 quarters · filed 2025-04-04 | $23.21M derived: sum of 3 quarters · filed 2025-04-04 | $28.53M 20-F · filed 2025-04-04 | ||||
| 2022-09-30 | $8.32M 10-Q · filed 2022-11-10 | $14.57M derived: sum of 2 quarters · filed 2023-08-14 | $19.89M 10-Q · filed 2022-11-10 | $24.91M derived: sum of 4 quarters · filed 2024-03-28 | ||||
| 2022-06-30 | $6.25M 6-K · filed 2023-08-14 | $11.57M 6-K · filed 2023-08-14 | $16.60M derived: sum of 3 quarters · filed 2024-03-28 | $19.49M derived: sum of 4 quarters · filed 2024-03-28 | ||||
| 2022-03-31 | $5.32M 10-Q · filed 2023-05-11 | $10.34M derived: sum of 2 quarters · filed 2024-03-28 | $13.23M derived: sum of 3 quarters · filed 2024-03-28 | $15.99M derived: sum of 4 quarters · filed 2024-03-28 | ||||
| 2021-12-31 | $5.02M derived: 20-F 12 month − 10-Q 9 month · filed 2024-03-28 | $7.92M derived: sum of 2 quarters · filed 2024-03-28 | $10.67M derived: sum of 3 quarters · filed 2024-03-28 | $12.37M 20-F · filed 2024-03-28 | ||||
| 2021-09-30 | $2.89M 10-Q · filed 2022-11-10 | $5.64M derived: sum of 2 quarters · filed 2022-11-10 | $7.34M 10-Q · filed 2022-11-10 | $9.29M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $2.75M 10-Q · filed 2022-08-12 | $4.45M 10-Q · filed 2022-08-12 | $6.39M derived: sum of 3 quarters · filed 2022-08-12 | $7.62M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $1.70M 10-Q · filed 2022-05-12 | $3.64M derived: sum of 2 quarters · filed 2022-05-12 | $4.87M derived: sum of 3 quarters · filed 2022-05-12 | $5.97M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $3.17M derived: sum of 2 quarters · filed 2022-03-30 | $4.27M derived: sum of 3 quarters · filed 2022-03-30 | $5.97M 10-K · filed 2022-03-30 | $11.71M 10-K · filed 2021-03-09 | |||
| 2020-09-30 | $1.23M 10-Q · filed 2021-11-12 | $2.46M 10-Q · filed 2020-11-16 | $2.33M derived: sum of 2 quarters · filed 2021-11-12 | $4.03M 10-Q · filed 2021-11-12 | $9.48M 10-Q · filed 2020-11-16 | $9.69M derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $1.10M 10-Q · filed 2021-08-13 | $3.48M 10-Q · filed 2020-08-14 | $2.81M 10-Q · filed 2021-08-13 | $7.03M 10-Q · filed 2020-08-14 | $8.47M derived: sum of 3 quarters · filed 2021-08-13 | $15.74M derived: sum of 4 quarters · filed 2021-08-13 | ||
| 2020-03-31 | $1.70M 10-Q · filed 2021-05-13 | $3.54M 10-Q · filed 2020-05-07 | $7.37M derived: sum of 2 quarters · filed 2021-05-13 | $14.64M derived: sum of 3 quarters · filed 2021-05-13 | $19.18M derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | $5.66M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $12.93M derived: sum of 2 quarters · filed 2021-03-09 | $17.47M derived: sum of 3 quarters · filed 2021-03-09 | $22.90M 10-K · filed 2021-03-09 | ||||
| 2019-09-30 | $7.27M 10-Q · filed 2020-11-16 | $11.81M derived: sum of 2 quarters · filed 2020-11-16 | $17.23M 10-Q · filed 2020-11-16 | |||||
| 2019-06-30 | $4.54M 10-Q · filed 2020-08-14 | $9.96M 10-Q · filed 2020-08-14 | ||||||
| 2019-03-31 | $5.43M 10-Q · filed 2020-05-07 | |||||||
| 2018-12-31 | $13.04M 10-K · filed 2020-03-17 |